These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1091 related items for PubMed ID: 18645496

  • 1. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 2. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D, Wissing KM, Ghisdal L, Broeders N, Touly M, Hoang AD, Loi P, Mboti F, Donckier V, Vereerstraeten P, Abramowicz D.
    Transplantation; 2008 Apr 15; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [Abstract] [Full Text] [Related]

  • 3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 15; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 4. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.
    Jung GO, Yoon MR, Kim SJ, Sin MJ, Kim EY, Moon JI, Kim JM, Choi GS, Kwon CH, Cho JW, Lee SK.
    Transplant Proc; 2010 Apr 15; 42(3):705-9. PubMed ID: 20430152
    [Abstract] [Full Text] [Related]

  • 5. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug 15; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 6. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002 Aug 15; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for the development of delayed graft function in deceased donor renal transplants.
    Jushinskis J, Trushkov S, Bicans J, Suhorukov V, Shevelev V, Ziedina I, Rozental R.
    Transplant Proc; 2009 Mar 15; 41(2):746-8. PubMed ID: 19328971
    [Abstract] [Full Text] [Related]

  • 8. Major effects of delayed graft function and cold ischaemia time on renal allograft survival.
    Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C.
    Nephrol Dial Transplant; 2006 Jun 15; 21(6):1689-96. PubMed ID: 16490743
    [Abstract] [Full Text] [Related]

  • 9. Optimal use of older donors and recipients in kidney transplantation.
    Stratta RJ, Sundberg AK, Rohr MS, Farney AC, Hartmann EL, Roskopf JA, Iskandar SS, Hairston G, Kiger DF, Gautreaux MD, Anderson TK, Adams PL.
    Surgery; 2006 Mar 15; 139(3):324-33. PubMed ID: 16546496
    [Abstract] [Full Text] [Related]

  • 10. Impact of recipient and donor nonimmunologic factors on the outcome of deceased donor kidney transplantation.
    Shaheen MF, Shaheen FA, Attar B, Elamin K, Al Hayyan H, Al Sayyari A.
    Transplant Proc; 2010 Mar 15; 42(1):273-6. PubMed ID: 20172328
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppression with antithymocyte globulin in renal transplantation: better long-term graft survival.
    Martins L, Fonseca I, Almeida M, Henriques AC, Dias L, Sarmento AM, Cabrita A.
    Transplant Proc; 2005 Mar 15; 37(6):2755-8. PubMed ID: 16182802
    [Abstract] [Full Text] [Related]

  • 12. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 13. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Jan 27; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

  • 14. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ, da Silva Quadros KR, Santos RL, Alves-Filho G, Mazzali M.
    Transplant Proc; 2009 Apr 27; 41(3):849-51. PubMed ID: 19376369
    [Abstract] [Full Text] [Related]

  • 15. Creatinine reduction ratio: a useful marker to identify medium and high-risk renal transplants.
    Vilar E, Varagunam M, Yaqoob MM, Raftery M, Thuraisingham R.
    Transplantation; 2010 Jan 15; 89(1):97-103. PubMed ID: 20061925
    [Abstract] [Full Text] [Related]

  • 16. Recipient and donor body mass index as important risk factors for delayed kidney graft function.
    Weissenbacher A, Jara M, Ulmer H, Biebl M, Bösmüller C, Schneeberger S, Mayer G, Pratschke J, Öllinger R.
    Transplantation; 2012 Mar 15; 93(5):524-9. PubMed ID: 22362367
    [Abstract] [Full Text] [Related]

  • 17. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 18. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan 15; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

  • 19. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
    Sáinz MM, Toro JC, Poblete HB, Perez LF, Nicovani VH, Carrera MG.
    Transplant Proc; 2009 Jan 15; 41(6):2655-8. PubMed ID: 19715994
    [Abstract] [Full Text] [Related]

  • 20. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J, RAD A2420 Study Group.
    Transplantation; 2009 Jul 15; 88(1):69-76. PubMed ID: 19584683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.